{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:49:09Z","timestamp":1784630949196,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.euroneuro.2011.09.003","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T03:19:07Z","timestamp":1318562347000},"page":"364-373","source":"Crossref","is-referenced-by-count":78,"title":["Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels"],"prefix":"10.1016","volume":"22","author":[{"given":"Katrina","family":"Weston-Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2011.09.003_bb0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2006.6","article-title":"Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents","volume":"14","author":"Albaugh","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0315","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diab. Care"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0350","series-title":"Australian Code of Practice for the Care and Use of Animals for Scientific Purposes","author":"Australian Government National Health and Medical Research Council","year":"2004"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejphar.2009.01.047","article-title":"Muscarinic M1, M3 receptors function in the brainstem of streptozotocin induced diabetic rats: their role in insulin secretion from the pancreatic islets as a function of age","volume":"608","author":"Balakrishnan","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.regpep.2007.08.024","article-title":"The vagus nerve, food intake and obesity","volume":"149","author":"Berthoud","year":"2008","journal-title":"Regul. Pept."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0030","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1210\/er.2003-0026","article-title":"The cellular fate of glucose and its relevance in Type 2 diabetes","volume":"25","author":"Bouche","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/1096-9861(20010319)431:4<405::AID-CNE1079>3.0.CO;2-D","article-title":"Parasympathetic and sympathetic control of the pancreas: a role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake","volume":"431","author":"Buijs","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2008.12.012","article-title":"Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model","volume":"108","author":"Chintoh","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0045","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/JCP.0b013e318184b4c5","article-title":"Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration","volume":"28","author":"Chintoh","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2008.06.006","article-title":"Insulin resistance following continuous, chronic olanzapine treatment: an animal model","volume":"104","author":"Chintoh","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0055","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.pnpbp.2010.04.003","article-title":"The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine","volume":"34","author":"Chiu","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.jcp.0000237947.80764.d9","article-title":"The early effect of olanzapine and risperidone on insulin secretion in atypical-naive schizophrenic patients","volume":"26","author":"Chiu","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0065","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/JCP.0b013e3181bfe13e","article-title":"30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice","volume":"29","author":"Coccurello","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pharmthera.2010.04.008","article-title":"Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design","volume":"127","author":"Coccurello","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0075","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/sj.ijo.0801913","article-title":"The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis","volume":"25","author":"Cone","year":"2001","journal-title":"Int. J. Obes. Relat. Disord."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0080","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1176\/appi.ajp.158.6.918","article-title":"Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment","volume":"158","author":"Crook","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.mehy.2010.11.013","article-title":"Vagus nerve stimulation as a strategy to prevent and manage metabolic syndrome","volume":"76","author":"Das","year":"2010","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.pnpbp.2007.02.009","article-title":"Olanzapine treatment decreases the density of muscarinic M2 receptors in the dorsal vagal complex of rats","volume":"31","author":"Deng","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.physbeh.2009.01.009","article-title":"The versatility of the vagus","volume":"97","author":"Dockray","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0320","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.53.7.1714","article-title":"Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in [M.sub.3] muscarinic acetylcholine receptor-deficient mice. (Islet studies)","volume":"53","author":"Duttaroy","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0105","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1210\/en.2010-0519","article-title":"Beneficial metabolic effects caused by persistent activation of {beta}-cell M3 muscarinic acetylcholine receptors in transgenic mice","volume":"151","author":"Gautam","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cmet.2006.09.008","article-title":"Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency","volume":"4","author":"Gautam","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0115","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cmet.2006.04.009","article-title":"A critical role for [beta] cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo","volume":"3","author":"Gautam","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jad.2008.11.015","article-title":"Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects","volume":"116","author":"Gibbons","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0125","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1210\/er.22.5.565","article-title":"Mechanisms and physiological significance of the cholinergic control of pancreatic {beta}-cell function","volume":"22","author":"Gilon","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jnr.21491","article-title":"Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain","volume":"86","author":"Han","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jpsychires.2008.06.001","article-title":"Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study","volume":"43","author":"Haro","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0140","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2337\/diabetes.54.5.1552","article-title":"Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia","volume":"54","author":"Johnson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0150","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1210\/en.143.1.185","article-title":"Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations","volume":"143","author":"Lee","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0160","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0306-4522(94)90017-5","article-title":"Localization of muscarinic M3 receptor protein and M3 receptor binding in rat brain","volume":"63","author":"Levey","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0165","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.2337\/db09-0522","article-title":"Hepatic muscarinic acetylcholine receptors are not critically involved in maintaining glucose homeostasis in mice","volume":"58","author":"Li","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0170","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1113\/jphysiol.2003.049122","article-title":"Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathways in the rat","volume":"552","author":"Li","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s005350050328","article-title":"Regulation of cholecystokinin secretion in humans","volume":"35","author":"Liddle","year":"2000","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0180","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0185","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2133\/dmpk.20.368","article-title":"Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus","volume":"20","author":"Matsui-Sakata","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0190","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0014-2999(89)90359-2","article-title":"Direct labeling of rat M3-muscarinic receptors by [3H]4DAMP","volume":"166","author":"Michel","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200519001-00001","article-title":"Second-generation atypical antipsychotics and metabolic effects. A comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0200","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.lfs.2005.04.006","article-title":"Necessity of intracellular cyclic AMP in inducing gastric acid secretion via muscarinic M3 and cholecystokinin2 receptors on parietal cells in isolated mouse stomach","volume":"77","author":"Ochi","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0205","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.diabet.2008.03.003","article-title":"Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study","volume":"34","author":"Oriot","year":"2008","journal-title":"Diab. Metab."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0210","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/JCP.0b013e318172b8e6","article-title":"Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment","volume":"28","author":"Perez-Iglesias","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1034\/j.1600-0447.2002.2c257a.x","article-title":"Olanzapine-induced destabilization of diabetes in the absence of weight gain","volume":"105","author":"Ramankutty","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0225","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0230","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.lfs.2004.03.034","article-title":"Alterations in the muscarinic M1 and M3 receptor gene expression in the brain stem during pancreatic regeneration and insulin secretion in weanling rats","volume":"75","author":"Renuka","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment \u2014 pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0240","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI109744","article-title":"Consequences of ventromedial hypothalamic lesions upon insulin and glucagon secretion by subsequently isolated perfused pancreases in the rat","volume":"65","author":"Rohner-Jeanrenaud","year":"1980","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tem.2010.10.004","article-title":"Novel insights into the function of [beta]-cell M3 muscarinic acetylcholine receptors: therapeutic implications","volume":"22","author":"Ruiz de Azua","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0250","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1469-7793.2000.00331.x","article-title":"Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro","volume":"525","author":"Shen","year":"2000","journal-title":"J. Physiol."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0255","first-page":"289","article-title":"Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes. Methods Find","volume":"27","author":"Silvestre","year":"2005","journal-title":"Exp. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0260","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.7268408","article-title":"Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat","volume":"213","author":"Smith","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0265","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eurpsy.2009.01.001","article-title":"How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins","volume":"24","author":"Starrenburg","year":"2009","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0270","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0006-8993(01)02746-9","article-title":"Excitatory stimulation of neurons in the arcuate nucleus inhibits gastric acid secretion via vagal pathways in anesthetized rats","volume":"913","author":"Tebbe","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0275","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.neuroscience.2006.03.011","article-title":"Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain","volume":"140","author":"Terry","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0280","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1006\/bbrc.2001.4518","article-title":"Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration","volume":"281","author":"Toshinai","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0285","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbr.2010.10.039","article-title":"Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats","volume":"217","author":"Weston-Green","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0325","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/endo-126-2-765","article-title":"Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats","volume":"126","author":"White","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0295","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35065604","article-title":"Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean","volume":"410","author":"Yamada","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0300","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2008.12.029","article-title":"Activation of muscarinic M-3 receptor may decrease glucose uptake and lipolysis in adipose tissue of rats","volume":"451","author":"Yang","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0305","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11064-006-9266-9","article-title":"Effects of typical and atypical antipsychotic drugs on rat brain muscarinic receptors","volume":"32","author":"Zavitsanou","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.euroneuro.2011.09.003_bb0310","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0022-3565(25)10285-1","article-title":"Autoradiographic mapping of M3 muscarinic receptors in the rat brain","volume":"264","author":"Zubieta","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X11002185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X11002185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T22:08:27Z","timestamp":1741817307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X11002185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0924977X11002185"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2011.09.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}